Cancer is a genetic disease. A few gene mutations can transform a normal cell into a malignant cancer cell.

HAI YAN

CHIEF SCIENTIST, GENETRON HEALTH

Genetron Health's oncology platform covers multiple cancers. Our key capabilities include by detecting unique gene mutations in patients, assisting patients in selecting targeted drugs and chemotherapeutics, evaluating the efficacy of immunotherapy, dynamically monitoring the progress of drug resistance and other diseases treatment, and assisting in formulating and optimizing clinical trials treatment plan to achieve personalized diagnosis and treatment.

...

MAJOR TUMOR TYPES WE COVER

LUNG
BRAIN
LIVER
COLON
STOMACH
THYROID
BREAST
BLADDER

COMPREHENSIVE MOLECULAR
DIAGNOSTIC SOLUTIONS

01

A number of IVD products approved for oncology

Precision diagnostics use methods in molecular biology to detect changes in the structure or expression of genetic material in organisms, to produce diagnoses. Genetron Health's IVD platform provides solutions for molecular diagnosis by using core fluorescent quantitative PCR, digital PCR, and high-throughput sequencing (NGS) systems.

02

LABORATORY DEVELOPED TEST

Genetron Health LDT products can cover pan-solid tumor related genes more comprehensively, with both tissue biopsies and liquid biopsies. The products play roles ranging from single-gene first-generation sequencing to small and medium-sized panels centered on targeted therapy and typing prognosis of certain cancer types, and large panels recommended by the comprehensive diagnosis and treatment of multiple types of cancer, based on NGS technology. Meanwhile, our products can provide customized testing services for drug R&D clinical trial partnerships.